¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) 2020³â ´ëÇѺ´¸®ÇÐȸ °¡À»Çмú´ëȸ : 2020-11-06

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) 2020³â ´ëÇѺ´¸®ÇÐȸ °¡À»Çмú´ëȸ : 2020-11-06
±³À°ÀÏÀÚ : 2020-11-06
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À°(½Ç½Ã°£È­»ó°­ÀÇ)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2020³â ´ëÇѺ´¸®ÇÐȸ °¡À»Çмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇѺ´¸®ÇÐȸ
´ã´çÀÚ : ´ëÇѺ´¸®ÇÐȸ
¿¬¶ôó : 02-795-3094  
À̸ÞÀÏ : ksphe@kams.or.kr      
±³À°Á¾·ù : º´¸®°ú      
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 36ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í ´ëÇѺ´¸®ÇÐȸ Á¤È¸¿ø : 70,000¿ø/´ëÇѺ´¸®ÇÐȸ ÁØȸ¿ø(±ºÀÇ°üÆ÷ÇÔ) : 50,000/ ºñȸ¿ø : 100,000¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 09:00~10:00 Keynote Lecture (3):How Twitter and Facebook Changed My Life: The Role of SocialMedia in Pathology and Medicine  Jerad Gardner(Geisinger Medical Center) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 10:00~10:25 Short Course C:Updates on Bone and Soft Tissue Tumors: Let''s Upgrade-What''s new in the 2019 WHO for bone tumors  ¹Ú¿ë±¸(U2Bio) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 10:25~10:50 Short Course C:Updates on Bone and Soft Tissue Tumors: Let''s Upgrade-Emphasis on Jaffe''s diagnostic triangle and management ofchodrosarcoma  ¹Ú¿øÁ¾(ÀÇÁ¤ºÎ¼º¸ðº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 10:50~11:15 Short Course C:Updates on Bone and Soft Tissue Tumors: Let''s Upgrade-Pseudosarcomatous lesion  ±è°æÈñ(¼¼Á¾Ãæ³²´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 11:15~11:40 Short Course C:Updates on Bone and Soft Tissue Tumors: Let''s Upgrade-Round cell soft tissue tumors  ±è»ó°â(¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 11:40~11:50 Short Course C:Updates on Bone and Soft Tissue Tumors: Let''s Upgrade-Q & A  () 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 11:50~12:00 Short Course C:Updates on Bone and Soft Tissue Tumors: Let''s Upgrade-Quiz  () 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 13:00~14:00 Keynote Lecture (4):Classification of Renal Tumors: Past, Present, and Future(½ÅÀåÁ¾¾çÀÇ ºÐ·ù: °ú°Å, ÇöÀç, ¹Ì·¡)  ÃÖÂù(È­¼øÀü³²´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 14:00~14:12 ±¸¿¬B-Clinicopathological analysis of 14 patients with pediatric-type low grade B-cell lymphomas including pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma  ÀÓ¼ÒÁ¤(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 14:12~14:24 ±¸¿¬B-Comparison of Ki-67 Labeling Index Patterns of Diffuse Large B-Cell Lymphomas and Burkitt Lymphomas Using Image Analysis  Á¤¿ä¼Á(ÀÇÁ¤ºÎ¼º¸ðº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 14:24~14:36 ±¸¿¬B-Histologic sub and its relationship with the targetable genomic features in solid-predominant lung adenocarcinoma  ¾Èº¸°æ(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 14:36~14:48 ±¸¿¬B-Comprehensive comparison of 22C3 and SP263 PD-L1 expression using routine clinical and conditioned archives of Non-Small-Cell Lung Cancer  ±èÅÂÁ¤(ÀÇÁ¤ºÎ¼º¸ðº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 14:48~15:00 ±¸¿¬B-CDX2 loss and SATB2 loss are differentially associated with underlying clinicopathologic and molecular features in colorectal carcinomas according to microsatellite instability status  ÀÌÁö¾Ö(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 15:00~15:12 ±¸¿¬B-PTEN Protein Loss and Loss-of-Function Mutations in Gastric Cancers: The Relationship with Microsatellite Instability, EBV, HER2, and PD-L1 Expression  ±èºû³ª¸®(¿ï»ê´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 15:12~15:24 ±¸¿¬B-Microvascular invasion-based integrated prognostic classification to predict survival in patients with hepatocellular carcinoma (HCC)  È²À±Á¤(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 06ÀÏ keymedi 15:24~15:36 ±¸¿¬B-Molecular risk stratification in metastatic differentiated thyroid cancers  Á¤Âù±Ç(¼­¿ï¼º¸ðº´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) 2020³â ´ëÇѺ´¸®ÇÐȸ °¡À»Çмú´ëȸ : 2020-11-06""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2020³â ´ëÇÑÇǺÎÁø±ÕÇÐȸ ¼øȸ¿¬¼ö±³À° : 2020-11-06
´ÙÀ½±Û ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ë±¸․°æºÏÁöȸ Á¦1Â÷ ¿¬¼ö±³À° : 2020-11-06
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
602 ¼­¿ï 2018³â ´ëÇÑÀÓ»óÅëÁõÇÐȸ Ãß°èÇмú´ëȸ ¿öÅ©¼ó : 2018-09-15 0 1,232 2018-08-29
601 ¼­¿ï 2018³â ´ëÇÑÀÓ»óÅëÁõÇÐȸ Ãß°èÇмú´ëȸ ¿¬¼ö°­Á : 2018-09-15 0 947 2018-08-29
600 ±¤ÁÖ Àü³²´ëÇб³º´¿ø °íÀ§Çè »ê¸ð ½Å»ý¾Æ ÅëÇÕÄ¡·á¼¾ÅÍ °³¼Ò 1Áֳ⠱â³ä ½ÉÆ÷Áö¾ö : 2018-09-15 0 802 2018-08-29
599 ºÎ»ê ºÎ»ê´ëÇб³º´¿ø Á¦5ȸ ´ëÇÑÇǺÎÁø±ÕÇÐȸ ¿¬¼ö±³À° : 2018-09-14 0 1,524 2018-08-29
598 °æ±â °Ç°­º¸Çè°ø´ÜÀϻ꺴¿ø À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ : 2018-09-14 1 736 2018-08-29
597 ¼­¿ï ½ÅÃ̼¼ºê¶õ½ºº´¿ø ´ëÇѼҾƳ»ºÐºñÇÐȸ 2018³âµµ Á¦3Â÷ Áý´ãȸ : 2018-09-14 0 1,144 2018-08-29
596 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ : 2018-09-13 0 642 2018-08-29
595 °æ±â ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø û°¢/ÀüÁ¤±â´É °Ë»ç°¡ Á¤»óÀÎ ¾îÁö·³ ȯÀÚÀÇ Áø´Ü ¹× Ä¡·á : 2018-09-13 0 1,521 2018-08-29
594 Àü³² ¿ø±¤´ëÇб³º´¿ø ´ëÇѽŻý¾ÆÇÐȸ È£³²Áöȸ ¿¬¼ö°­Á : 2018-09-13 0 2,194 2018-08-29
593 ´ë±¸ ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ EMDRÀÇ À̷аú ½ÇÁ¦ : 2018-09-13 0 650 2018-08-29
592 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ 2018 ´ç´¢º´ ¿¹¹æ¿¬±¸»ç¾÷´Ü Ãß°è ½ÉÆ÷Áö¾ö : 2018-09-13 0 1,747 2018-08-29
591 ÃæºÏ ÃæºÏ´ëÇб³º´¿ø 2018³âµµ Á¦2ȸ ´ëÇѳ»°úÇÐȸ ÃæºÏÁöȸ ÇмúÇà»ç : 2018-09-13 0 1,128 2018-08-29
590 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ 9¿ù ¿ù·ÊÁý´ãȸ : 2018-09-13 0 1,183 2018-08-29
589 ´ë±¸ 2018 Á¦2Â÷ ´ë±¸°æºÏ ¿°Áõ¼º ÀåÁúȯ ³×Æ®¿öÅ© ¿¬±¸È¸ ±³À° ¼¼¹Ì³ª : 2018-09-12 0 786 2018-08-29
588 ÀÎõ ÀÎÇϴ뺴¿ø Á¤¹ÐÀÇ·á¼¾ÅÍ °³¼Ò±â³ä ½ÉÆ÷Áö¾ö : 2018-09-12 0 748 2018-08-29
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷